diethyl 2-hydroxyiminomalonate, 90%, 1g

2-Oxovaleric Acid>95.0%(GC)1mL

1,8-Dibromopyrene, 95.0%, 250mg

Phenyl vinyl sulfone, 96.0%, 1g

2-PROPANOL, 1-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-, (2S)-, 95.0%, 250mg

SRC KINASE INHIBITOR I, 95%, 1mg

3,5-Dibromo-4-methylanisole, 95.0%, 10g

N'-[1-Cyclopropylamino-2-phenoxyethylidene]hydrazinecarboxylic acid tert-butyl ester, 95.0%, 500mg

2-N,N-Diethylsulfamoylphenylboronic acid, 95.0%, 250mg

ETHYL 2-((4-METHOXYBENZYL)AMINO)ACETATE HCL, 95%, 250mg

3-Acetyl-7(1H)-azaindole, 95.0%, 1g

D(+)-malic acid, min. 99%, for biochemistry, 5 g, plastic packaging.

Sodium 4-(2-(2-(2-chloro-3-(2-(3,3-dimethyl-1-(4-sulfonatobutyl)-3H-indol-1-ium-2-yl)vinyl)cyclohex-2-en-1-ylidene)ethylidene)-3,3-dimethylindolin-1-yl)butane-1-sulfonate, 98%, 5g